References

Acion L, Peterson JJ, Temple S, et al: Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Stat Med 25:591-602, 2006 [PubMed]

Altman DG, Schulz KF, Hoher D, et al: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. CONSORT Group (Consolidated Standards of Reporting Trials). Ann Intern Med 134:663-694, 2001 [PubMed]

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000

Andersen PK, Borch-Johnsen K, Deckert T, et al: A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 41:921-932, 1985 [PubMed]

Berger MPF: A comparison of efficiencies of longitudinal, mixed longitudinal, and cross-sectional designs. Journal of Educational Statistics 11:171-181, 1986

Blomqvist N: On the bias caused by regression toward the mean in studying the relation between change and the initial value. J Clin Periodontol 13:34-37, 1986

Borenstein M: The case for confidence intervals in controlled clinical trials. Control Clin Trials 15:411-428, 1994 [PubMed]

Borenstein M: Hypothesis testing and effect size estimation in clinical trials. Ann Allergy Asthma Immunol 78:5-16, 1997 [PubMed]

Borenstein M: The shift from significance testing to effect size estimation, in Comprehensive Clinical Psychology (Bellak AS, Hersen M, editors-in-chief), Vol 3: Research Methods (Schooler NR, volume editor). Burlington, MA, Elsevier Science, 1998, pp 319-349

Campbell DT, Kenny DA: A Primer on Regression Artifacts. New York, Guilford, 1999

Cohen J: The cost of dichotomization. Applied Psychological Measurement 7:249-253, 1983

Crabbe JC, Wahlsten D, Dudek BC: Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-1672, 1999 [PubMed]

Davis CE: The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 104:493-498, 1976 [PubMed]

deLeeuw J, Kreft I: Random coefficient models for multilevel analysis. Journal of Educational Statistics 11:57-85, 1986

Freedman B: Equipoise and the ethics of clinical research. N Engl J Med 317:141-145, 1987 [PubMed]

Grissom RJ: Probability of the superior outcome of one treatment over another. J Appl Psychol 79:314-316, 1994

Grissom RJ, Kim JJ: Effect Sizes for Research: A Broad Practical Approach. Mahwah, NJ, Lawrence Erlbaum, 2005

Hoagwood K, Hibbs E, Brent D, et al: Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. J Consult Clin Psychol 63:683-687, 1995 [PubMed]

Hill AB: Medical ethics and controlled trials. BMJ 1(5337):1043-1049, 1963 [PubMed]

Humphreys K, Weisner C: Use of exclusion criteria in selecting research patients and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry 157:588-594, 2000 [Full Text] [PubMed]

Humphreys K, Weingardt KR, Horst D, et al: Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction 100:1249-1257, 2005 [PubMed]

Jones LV, Tukey JW: A sensible formulation of the significance test. Psychol Methods 5:411-414, 2000 [PubMed]

Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 562-563, 1958

Kemmler G, Hummer M, Widschwendter C, et al: Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs. Arch Gen Psychiatry 62:1305-1312, 2005 [PubMed]

Khan A, Warner HA, Brown WA: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 57:311-317, 2000[PubMed]

Khan A, Khan SR, Leventhal RM, et al: Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am J Psychiatry 158:1449-1454, 2001 [Full Text] [PubMed]

Khan A, Kolts RL, Brodhead AE, et al: Suicide risk analysis among patients assigned to psychotropics and placebo. Psychopharmacol Bull 39:6-14, 2006 [PubMed]

Kraemer HC: To increase power in randomized clinical trials without increasing sample size. Psychopharmacol Bull 27:217-224, 1991 [PubMed]

Kraemer HC: Toward non-parametric and clinically meaningful moderators and mediators. Stat Med 27:1679-1692, 2008 [PubMed]

Kraemer HC, Blasey C: Centring in regression analysis: a strategy to prevent errors in statistical inference. Int J Methods Psychiatr Res 13:141-151, 2004 [PubMed]

Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 59:990-996, 2006 [PubMed]

Kraemer HC, Robinson TN: Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions? Contemp Clin Trials 26:518-529, 2005 [PubMed]

Kraemer HC, Thiemann S: How Many Patients? Statistical Power Analysis in Research. Newbury Park, CA, Sage, 1987

Kraemer HC, Thiemann SA: A strategy to use "soft" data effectively in randomized clinical trials. J Consult Clin Psychol 57:148-154, 1989 [PubMed]

Kraemer HC, Frank E, Kupfer DJ: Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 296:1286-1289, 2006 [PubMed]

Kraemer HC, Kiernan M, Essex MJ, et al: How and why criteria defining moderators and mediators differ between the Baron and Kenny and MacArthur approaches. Health Psychol 27:S101-S108, 2008

Leber P: The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Biol Psychiatry 47:699-706, 2000 [PubMed]

Leber PD, Davis CS: Threats to the validity of clinical trials employing enrichment strategies for sample selection. Control Clin Trials 19:178-187, 1998 [PubMed]

MacCallum RC, Zhang S, Preacher KJ, et al: On the practice of dichotomization of quantitative variables. Psychol Methods 7:19-40, 2002 [PubMed]

Meehl PE: Theory testing in psychology and physics: a methodological paradox. Philos Sci 34:103-115, 1967

Meinert CL: Clinical Trials: Design, Conduct, and Analysis. New York, Oxford University Press, 1986

MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999

Rennie D: How to report randomized controlled trials: the CONSORT Statement. JAMA 276:649, 1996 [PubMed]

Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 331:394-398, 1994 [PubMed]

Rubin DB: Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66:688-701, 1974

Rubin DB: Teaching statistical inference for causal effects in experiments and observational studies. Journal of Educational and Behavioral Statistics 29:343-367, 2004

Rush AJ Jr, First MB, Blacker D (eds): Handbook of Psychiatric Measures, 2nd Edition. Washington, DC, American Psychiatric Publishing, 2008

Senn S: Regression to the mean. Stat Methods Med Res 6:99-102, 1997

Stigler SM: Regression towards the mean, historically considered. Stat Methods Med Res 6:103-114, 1997 [PubMed]

Storosum JG, Wohlfarth T, Gispen-de Wied CC, et al: Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry 162:799-802, 2005 (Comment in: Am J Psychiatry 163:329, 2006)

Ware JH: Linear models for the analysis of longitudinal studies. Am Stat 39:95-101, 1985

Wen L, Badgett R, Cornell J: Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm 62:2031-2036, 2005 [PubMed]

Copyright © 2009 American Psychiatric Publishing, Inc. All Rights Reserved.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment